Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster viewing 03

272P - Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: Experience from a tertiary cancer center in eastern part of India

Date

03 Dec 2022

Session

Poster viewing 03

Topics

Molecular Oncology

Tumour Site

Gastrointestinal Cancers

Presenters

Tanuj Chawla

Citation

Annals of Oncology (2022) 33 (suppl_9): S1533-S1539. 10.1016/annonc/annonc1130

Authors

T. Chawla1, J. Ghosh2, S. Ganguly2, B. Biswas2, N. Arora3, S. Vinarkar4, A. Patra5, A. Jha5, D. Mishra6, M.K. Mallath5

Author affiliations

  • 1 Clinical Pharmacology Department, TMC - Tata Medical Center, 700160 - Kolkata/IN
  • 2 Medical Oncology Dept, TMC - Tata Medical Center, 700160 - Kolkata/IN
  • 3 Molecular Biology, Unipath Specialty Laboratory, 380015 - Ahmedabad/IN
  • 4 Molecular Genetics, TMC - Tata Medical Center, 700160 - Kolkata/IN
  • 5 Digestive Diseases, TMC - Tata Medical Center, 700160 - Kolkata/IN
  • 6 Hematopathology, TMC - Tata Medical Center, 700160 - Kolkata/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 272P

Background

5-fluorouracil (5-FU) is a major component of chemotherapy regimens in gastrointestinal (GI) cancers. Mutation in Dihydropyrimidine Dehydrogenase (DPD) gene can cause severe 5-FU related toxicity. Identifying the mutation helps in predicting the toxicity and adjusting dose of 5-FU. Our study assesses and analyze the utility of DPD testing at our center.

Methods

Data of GI cancer patients who has been tested for DPD enzyme while planning chemotherapy (for both adjuvant and palliative settings) was extracted from our center’s electronic records from the 1st June 2016 to 31st December 2021 and evaluated. We collected demographics of the patients, genotypes of DPD gene, disease status, chemotherapy type and the associated toxicities.

Results

Total 211 patients were tested for the DPD gene with median age of 66 years (Female=78). 120 patients were found to have mutation. There were 6 different DPD genotypes in our dataset. Among mutated ones, 36% were female. Seven patients were homozygous for some DPD gene variants, most common was *9A (c.85 T>C; p.C29R) genotype. While 2 out of 7 had severe diarrhea (Grade 3/4, CTCAE V.5) during chemotherapy, no patient died of toxicity. Among mutated vs non-mutated patients, grade 3/4 diarrhoea was 25% vs 38% (Chi Sq (1, N = 65) = 4.39, p = .035), anemia was 10% vs 9% (Chi Sq (1, N=21) = 0.0007, p= .978), neutropenia was 9% vs 4% (Chi Sq (1, N=15) =1.78, p= .181), thrombocytopenia was 5% vs 3% (Chi Sq (1, N=9) = 0.36, p= .544), mucositis was 6% vs 1% (Chi Sq (1, N=9) = 3.92, p= .047). Most patients with Grade 3/4 toxicity were on combination chemotherapy. We found 9 different DPD genotypes in our population. Among them, *9A (c.85 T>C; p.C29R) caused most severe GI toxicity, *2A (c.14+1 G>A) genotype resulted in severe hematological and GI toxicity. We lost one patient to toxicity having heterozygous *6 (2194 G/A; p.V732I) mutation.

Conclusions

DPD gene testing can help in predicting the toxicity to 5-FU based chemotherapy. We found that diarrhea and mucositis were related to the DPD gene mutation more than anemia, neutropenia and thrombocytopenia. Genotype analysis should be an important part of the treatment plan for GI cancers.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Tanuj Chawla.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.

  • Analytics cookies help us improve our website by collecting and reporting information on its usage.

  • We use marketing cookies to build a profile of you as a user through your actions on our site in order to better understand your interests and provide you with pertinent suggestions.